Tradestie Institutional Equity Comparison Engine
MCHPP vs ALAB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ALAB Overall Edge
ALAB Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astera Labs, Inc. Common Stock (ALAB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MCHPP trades at N/M Forward P/E with 21.6% operating margin (+42.2% YoY revenue) versus ALAB at 31.0x Forward P/E and 25.5% operating margin (+153.7% YoY). In options structure, MCHPP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALAB sits in BREAKDOWN (31st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ALAB
MCHPP N/M vs ALAB 31.0x Fwd P/E
Growth & Margin Winner
ALAB
Op Margin 21.6% vs 25.5% ยท YoY +42.2% vs +153.7%
Momentum & Technical Winner
ALAB
1Y +0.8% vs +44.1% ยท 52W Pos 14% vs 28%
Options & Structure Winner
ALAB
UNCLASSIFIED (N/A IV) vs BREAKDOWN (31st %ile IV)
MCHPP
NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap
N/A
1M Return
-17.41%
1Y Return
+0.8%
Forward P/E
N/M
Unified AI Score
57.1 / 100
HOLD
Tech 74.0
Fund 61.0
Flow 50.0
Mom 60.0
ALAB
NASDAQ
Astera Labs, Inc. Common Stock
Semiconductors & Related Devices
$208.25
-6.12% 1D
Market Cap
$39.8B
1M Return
-27.14%
1Y Return
+44.15%
Forward P/E
31.0x
Unified AI Score
53.4 / 100
HOLD
Tech 45.0
Fund 57.0
Flow 67.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MCHPP +0.8%
ALAB +44.15%
Spread: +43.35 pp (ALAB Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MCHPP TTM Op. Margin: 21.6%
ALAB TTM Op. Margin: 25.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs ALAB. Trailing 12-month operating profitability (MCHPP 21.6% vs ALAB 25.5%) and valuation multiples (MCHPP N/M vs ALAB 31.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MCHPP | ALAB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $39.8B | Larger Scale | ALAB |
| Trailing P/E Ratio Valuation | N/M | 90.0x | Lower Multiple | ALAB |
| Forward P/E Ratio Valuation | N/M | 31.0x | Lower Multiple | ALAB |
| Revenue Growth (YoY) Growth | +42.2% | +153.7% | Higher Growth | ALAB |
| Operating Margin (TTM) Profitability | 21.6% | 25.5% | Higher Margin | ALAB |
| Net Profit Margin Profitability | 15.0% | 29.6% | Higher Margin | ALAB |
| Return on Equity (ROE) Capital Efficiency | 12.6% | 28.2% | Higher ROE | ALAB |
| 52-Week Range Position Momentum | 14% ($47โ$88) | 28% ($98โ$499) | Stronger Trend | ALAB |
| Beta / 30D Volatility Risk Regime | 2.16ฮฒ ยท 65% Vol | 4.24ฮฒ ยท 124% Vol | Lower Realized Risk | MCHPP |
| Unified Institutional Score Composite Signal | 57.1 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | MCHPP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MCHPP vs ALAB Buy Guide
MCHPP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ALAB
BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
31st %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MCHPP nor ALAB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.